Literature DB >> 30066422

Clinicopathological features of He Shou Wu-induced liver injury: This ancient anti-aging therapy is not liver-friendly.

Yan Wang1, Lan Wang1, Romil Saxena2, Aileen Wee3, Ruiyuan Yang1, Qiuju Tian1, Jiping Zhang4, Xinyan Zhao1, Jidong Jia1.   

Abstract

BACKGROUND & AIMS: Polygonum Multiflorum Thumb (PMT), an ancient anti-aging Chinese herb known traditionally as He Shou Wu, has side effects of liver toxicity. To determine the main clinical and pathological characteristics of liver toxicity induced by PMT and the clinical course after its cessation.
METHODS: Data of patients, diagnosed as drug-induced liver injury and hospitalised in Beijing Friendship Hospital from August 2005 to August 2017, were retrospectively reviewed. Clinical, pathological data and outcome after cessation of He Shou Wu were obtained and analysed. Kruskal-Wallis and Chi-square (χ2 ) tests were performed.
RESULTS: Twenty-nine patients with He Shou Wu-induced liver injury were enrolled. The median age was 53 years (range 15-74) and 75.9% (22/29) were women. The most common symptom was jaundice (79.3%, 23/29). Of nine patients with liver biopsies, six showed acute cholestatic hepatitis, two acute, and one chronic hepatocellular injury pattern. The latency, liver chemistries and outcomes were comparable between pure He Shou Wu (5 patients) and its compounds (24 patients). Twenty-five of 29 patients (86.2%) had normal serum alanine aminotransferase levels after 45 days (range: 10-138 days) and total bilirubin of 46 days (range: 0-551 days). One patient was rechallenged with He Shou Wu and two developed autoimmune features. One patient died of liver failure and three had chronic persistent liver injury.
CONCLUSIONS: The main clinicopathological injury pattern of He Shou Wu-induced liver injury is moderate to severe hepatitis with or without cholestasis. Most patients recover completely; however, chronic disease and death do occur.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  He Shou Wu; Polygonum Multiflorum Thumb; clinical course; drug-induced liver injury

Mesh:

Substances:

Year:  2018        PMID: 30066422     DOI: 10.1111/liv.13939

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  5 in total

1.  Comparative Studies on Multi-Component Pharmacokinetics of Polygonum multiflorum Thunb Extract After Oral Administration in Different Rat Models.

Authors:  Ninghui Ma; Yong Zhang; Liyan Sun; Yuan Zhao; Yue Ding; Tong Zhang
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

Review 2.  Drug-Induced Liver Injury: Highlights of the Recent Literature.

Authors:  Mark Real; Michele S Barnhill; Cory Higley; Jessica Rosenberg; James H Lewis
Journal:  Drug Saf       Date:  2019-03       Impact factor: 5.606

3.  Single-nucleotide polymorphisms of HLA and Polygonum multiflorum-induced liver injury in the Han Chinese population.

Authors:  Wan-Na Yang; Li-Li Pang; Ji-Yuan Zhou; Yuan-Wang Qiu; Liang Miao; Shou-Yun Wang; Xiang-Zhong Liu; Kang-An Tan; Wan-Wan Shi; Gui-Qiang Wang; Feng-Qin Hou
Journal:  World J Gastroenterol       Date:  2020-03-28       Impact factor: 5.742

4.  Beware of the Potential Risks for Polygoni Multiflori Caulis-Induced Liver Injury.

Authors:  Wei-Song Kong; Gui Zhou; Li-Wei Xu; Kun Wang; Yi-Ming Feng; Li-Yu Tao; Rui-Fang Xie; Ming Yang; Xin Zhou
Journal:  Front Pharmacol       Date:  2022-04-01       Impact factor: 5.988

5.  Herb-induced liver injury: Systematic review and meta-analysis.

Authors:  Vinícius Remus Ballotin; Lucas Goldmann Bigarella; Ajacio Bandeira de Mello Brandão; Raul Angelo Balbinot; Silvana Sartori Balbinot; Jonathan Soldera
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.